Ergotaminine

CAS: 639-81-6

Ref. 3D-XE180555

Produktinformation

• Name: Ergotaminine
• Synonyme: (5′α,8α)-12′-Hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione, 12'-Hydroxy-2'-methyl-5'a-(phenylmethyl)-8a-ergotaman-3',6',18-trione, 639-81-6, 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv., Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,8α)-, Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv., Isoergotamine, (5'alpha,8alpha)-5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman

Beschreibung

Ergotaminine is a drug used to treat migraine attacks. It belongs to the pharmacological agents and has a basic structure that is similar to ergotamine. Ergotamine is an alkaloid extracted from the fungus Claviceps purpurea, which is used as a drug for the treatment of migraine headaches. Ergotamine also has other pharmacological effects such as vasoconstriction and uterine contraction. Ergotamine can cause side effects such as nausea, vomiting, and diarrhea. One of its main disadvantages is that it can lead to drug interactions with other drugs because it interacts with cytochrome P450 enzymes in the liver by inhibiting them. Ergotamine also has analytical methods such as gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry, and fluorescence detection. Ergotamine can be used for treating infectious diseases such as carcinoid syndrome or angiogenic process caused by nonsteroidal anti-inflammatory drugs (NSAIDs

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 581.7 g/mol
• Formel: C₃₃H₃₅N₅O₅
• Reinheit: Min. 95%